Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Appl Physiol ; 121(12): 3399-3408, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34480633

ABSTRACT

PURPOSE: The aim of this study is to investigate the influence of the MCT1 T1470A polymorphism (rs1049434) on repeated sprint ability (RSA) and lactate accumulation after RSA testing. METHODS: Twenty-six elite Italian male football players (age: 17.7 ± 0.78 years; height: 179.2 ± 7.40 cm; weight: 72.1 ± 5.38 kg) performed RSA testing (6 × 30-m sprints with an active recovery between sprints), and lactate measurements were obtained at 1, 3, 5, 7, and 10 min post-exercise. Genotyping for the MCT1 T1470A polymorphism was performed using PCR. RESULTS: Genotype distributions were in Hardy-Weinberg equilibrium, being 42% wildtype (A/A), 46% heterozygotes (T/A), and 12% mutated homozygotes (T/T). Significant differences between genotypic groups were found in the two final sprint times of the RSA test. Under a dominant model, carriers of the major A-allele (Glu-490) in the dominant model showed a significantly lower sprint time compared to footballers with the T/T (Asp/Asp) genotype (5th Sprint time: A/A + T/A = 4.60 s vs TT = 4.97 s, 95% CI 0.07-0.67, p = 0.022; 6th Sprint: A/A + T/A = 4.56 s vs T/T = 4.87 s, 95% CI 0.05-0.57, p = 0.033). CONCLUSIONS: The T1470A (Glu490Asp) polymorphism of MCT1 was associated with RSA. Our findings suggest that the presence of the major A-allele (Glu-490) is favourable for RSA in football players.


Subject(s)
Athletic Performance , Lactates , Monocarboxylic Acid Transporters , Running , Symporters , Adolescent , Humans , Male , Athletic Performance/physiology , Genotype , Lactates/blood , Monocarboxylic Acid Transporters/genetics , Physical Endurance/genetics , Polymorphism, Single Nucleotide , Running/physiology , Symporters/genetics , Soccer
2.
3.
Plant Mol Biol ; 45(6): 631-40, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11430426

ABSTRACT

Pre-harvest sprouting (PHS) in sorghum is related to the lack of a normal dormancy level during seed development and maturation. Based on previous evidence that seed dormancy in maize is controlled by the vp1 gene, we used a PCR-based approach to isolate two Sorghum bicolor genomic and cDNA clones from two genotypes exhibiting different PHS behaviour and sensitivity to abscisic acid (ABA). The two 699 amino acid predicted protein sequences differ in two residues at positions 341 (Gly or Cys within the repression domain) and 448 (Pro or Ser) and show over 80, 70 and 60% homology to maize, rice and oat VP1 proteins respectively. Expression analysis of the sorghum vp1 gene in the two lines shows a slightly higher level of vp1 mRNA in the embryos susceptible to PHS than in those resistant to PHS during embryogenesis. However, timing of expression was different between these genotypes during this developmental process. Whereas for the former the main peak of expression was observed at 20 days after pollination (DAP), the peak in the latter was found at later developmental stages when seed maturation was almost complete. Under favourable germination conditions and in the presence of fluridone (an inhibitor of ABA biosynthesis), sorghum vp1 mRNA showed to be consistently correlated with sensitivity to ABA but not with ABA content and dormancy.


Subject(s)
Plant Proteins/genetics , Poaceae/genetics , Trans-Activators/genetics , Abscisic Acid , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA, Plant , Gene Expression , Genes, Plant , Germination , Molecular Sequence Data , Plant Proteins/physiology , Polymerase Chain Reaction/methods , Reverse Transcriptase Polymerase Chain Reaction , Seeds/growth & development , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Trans-Activators/physiology , Zea mays
4.
Fetal Diagn Ther ; 15(6): 335-7, 2000.
Article in English | MEDLINE | ID: mdl-11111213

ABSTRACT

Smith-Magenis syndrome is associated with a microdeletion of the short arm of chromosome 17 with phenotypic abnormalities including dysmorphic facies, self-injurious behavior, mental and neurologic disturbances, and congenital cardiac defects. The majority of patients present in mid-childhood or adulthood. We describe a fetus in which the diagnosis of Smith-Magenis syndrome was made at 16 weeks of gestation following amniocentesis for increased risk for Down syndrome detected by second-trimester maternal serum screening. Ultrasound evaluation revealed multiple fetal anomalies. The pregnancy was terminated at 20 weeks of gestation. Post-mortem findings included dysmorphic facial features, tetralogy of Fallot, a thymic duct remnant, pancreatic islet cell hyperplasia, and abnormal lung fissuring. This represents the second case of prenatally diagnosed Smith-Magenis syndrome. Molecular genetic techniques in the diagnosis of the Smith-Magenis syndrome and other small deletions are becoming an important tool in the genetic evaluation of ultrasound abnormalities.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Aberrations/diagnosis , Chromosomes, Human, Pair 17 , Gene Deletion , Prenatal Diagnosis , Abnormalities, Multiple/diagnosis , Adult , Chromosome Disorders , Female , Humans , Pregnancy
5.
Genet Test ; 4(1): 61-3, 2000.
Article in English | MEDLINE | ID: mdl-10794363

ABSTRACT

Fluorescence in situ hybridization (FISH) of chromosome-specific probes to interphase uncultured amniocytes was performed in cases in which follow-up amniocenteses were done for confirmation of previously detected mosaicism. FISH results were informative in all seven cases included in the study, and confirmed by subsequent cytogenetic analysis. FISH analysis provides rapid results for referral physicians and in most cases reassurance for patients within 24 hours of the follow-up aminocentesis. Although FISH studies are not considered accurate in determining a primary diagnosis of mosaicism in uncultured cells, the analysis is accurate and clinically useful when the diagnosis is known and mosaicism involving a specific chromosome needs to be confirmed in follow-up testing.


Subject(s)
Aneuploidy , In Situ Hybridization, Fluorescence , Mosaicism/genetics , Prenatal Diagnosis/methods , Trisomy/diagnosis , Amniocentesis , Amnion/cytology , Chromosomes, Human, Pair 12/genetics , Chromosomes, Human, Pair 13/genetics , Chromosomes, Human, Pair 7/genetics , Chromosomes, Human, Pair 9/genetics , Female , Follow-Up Studies , Humans , Karyotyping/methods , Predictive Value of Tests , Pregnancy , Time Factors , Trisomy/genetics , X Chromosome/genetics , Y Chromosome/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...